160 related articles for article (PubMed ID: 28002879)
1.
Tsipis AC; Karapetsas IN
Magn Reson Chem; 2017 Jul; 55(7):662-669. PubMed ID: 28002879
[TBL] [Abstract][Full Text] [Related]
2. Prediction of
Tsipis AC; Karapetsas IN
Magn Reson Chem; 2017 Feb; 55(2):145-153. PubMed ID: 27628024
[No Abstract] [Full Text] [Related]
3. Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.
Ermondi G; Caron G; Ravera M; Gabano E; Bianco S; Platts JA; Osella D
Dalton Trans; 2013 Mar; 42(10):3482-9. PubMed ID: 23263457
[TBL] [Abstract][Full Text] [Related]
4. Accurate prediction of 195Pt NMR chemical shifts for a series of Pt(II) and Pt(IV) antitumor agents by a non-relativistic DFT computational protocol.
Tsipis AC; Karapetsas IN
Dalton Trans; 2014 Apr; 43(14):5409-26. PubMed ID: 24519094
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and in vitro antiproliferative activity of [salophene]platinum(II) complexes.
Proetto MT; Liu W; Molchanov A; Sheldrick WS; Hagenbach A; Abram U; Gust R
ChemMedChem; 2014 Jun; 9(6):1176-87. PubMed ID: 24844419
[TBL] [Abstract][Full Text] [Related]
6. Chemistry and biological activity of platinum amidine complexes.
Michelin RA; Sgarbossa P; Sbovata SM; Gandin V; Marzano C; Bertani R
ChemMedChem; 2011 Jul; 6(7):1172-83. PubMed ID: 21630470
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
[TBL] [Abstract][Full Text] [Related]
8. Luminescent Pt
Lázaro A; Balcells C; Quirante J; Badia J; Baldomà L; Ward JS; Rissanen K; Font-Bardia M; Rodríguez L; Crespo M; Cascante M
Chemistry; 2020 Feb; 26(9):1947-1952. PubMed ID: 31909511
[TBL] [Abstract][Full Text] [Related]
9. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
10. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
11. Theoretical investigations and density functional theory based quantitative structure-activity relationships model for novel cytotoxic platinum(IV) complexes.
Varbanov HP; Jakupec MA; Roller A; Jensen F; Galanski MS; Keppler BK
J Med Chem; 2013 Jan; 56(1):330-44. PubMed ID: 23214999
[TBL] [Abstract][Full Text] [Related]
12. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
13. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
Wang H; Yang X; Zhao C; Wang PG; Wang X
Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
[TBL] [Abstract][Full Text] [Related]
14. Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs.
Piccinonna S; Margiotta N; Pacifico C; Lopalco A; Denora N; Fedi S; Corsini M; Natile G
Dalton Trans; 2012 Aug; 41(32):9689-99. PubMed ID: 22782180
[TBL] [Abstract][Full Text] [Related]
15. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
[TBL] [Abstract][Full Text] [Related]
16. First Attempts of the Use of
Pereira BTL; Gonçalves MA; Mancini DT; Kuca K; Ramalho TC
Molecules; 2019 Nov; 24(21):. PubMed ID: 31684009
[TBL] [Abstract][Full Text] [Related]
17. Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
Yap SQ; Chin CF; Hong Thng AH; Pang YY; Ho HK; Ang WH
ChemMedChem; 2017 Feb; 12(4):300-311. PubMed ID: 28028938
[TBL] [Abstract][Full Text] [Related]
18. A monofunctional platinum(II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition.
Wang B; Wang Z; Ai F; Tang WK; Zhu G
J Inorg Biochem; 2015 Jan; 142():118-25. PubMed ID: 25450026
[TBL] [Abstract][Full Text] [Related]
19. Novel cis-[(NHC)
Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
[TBL] [Abstract][Full Text] [Related]
20. Exploring the DNA binding/cleavage, cellular accumulation and topoisomerase inhibition of 2-hydroxy-3-(aminomethyl)-1,4-naphthoquinone Mannich bases and their platinum(II) complexes.
Neves AP; Pereira MX; Peterson EJ; Kipping R; Vargas MD; Silva FP; Carneiro JW; Farrell NP
J Inorg Biochem; 2013 Feb; 119():54-64. PubMed ID: 23186648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
